Introduction: cardiometabolic considerations in COVID-19
The journal is pleased to present a collection of timely articles that consider issues of relevance both to the current coronavirus disease 2019 (COVID-19) pandemic as it unfolds and to preparedness against future challenges.
While many uncertainties remain and much speculation continues to circulate, early insights into the importance of diabetes, obesity and cardiovascular disease to COVID-19 susceptibility and higher case fatality rates have been borne out by multiple studies. As Dhindsa et al . point out these cardiometabolic disorders represent a parallel non-communicable global challenge that will continue to present a threat to millions of individuals worldwide after the current coronavirus threat has passed. The full impact of the interruptions to aspects of preventive healthcare, including diabetes and cardiovascular disease, has yet to be quantified.
The journal has sought to fast track COVID-19 articles and they have been made available on the Cardiovascular Endocrinology & Metabolism website in the Online First section once accepted.
Conflicts of interest
There are no conflicts of interest.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
1. Dhindsa DS, Wong ND, Sperling L. Cardiovascular and cardiometabolic prevention: High level priority in the era of COVID-19. Cardiovasc Endocrinol Metab. 2020; 9:125–127